Showing results (31-40 of 580) with videos related to

Sort By:
Pageof 58
BMC Genomics|September 13, 2014
Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotypeSimone Feurstein, Frank G Rücker, Lars Bullinger, et al.
Oncotarget|November 2, 2017
Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapyMin Yang, Zengkai Pan, Kezhi Huang, et al.
Haematologica|November 4, 2005
Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemiaMichael Heuser, Luzie U Wingen, Doris Steinemann, et al.
Oncogene|May 29, 2002
Tumor suppressor genes in normal and malignant hematopoiesisUtz Krug, Arnold Ganser, H Phillip Koeffler
Methods in Molecular Biology (Clifton, N.J.)|December 27, 2008
Proteomics studies after hematopoietic stem cell transplantationEva M Weissinger, Petra Zürbig, Arnold Ganser
British Journal of Haematology|May 10, 2012
ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemiaFrederik Damm, Katharina Wagner, Kerstin Görlich, et al.
Hematology. American Society of Hematology. Education Program|December 4, 2016
Therapy-related myeloid neoplasms: does knowing the origin help to guide treatment?Michael Heuser
Current Drug Targets|August 17, 2002
Tumor cell-based vaccination in renal cell carcinoma: rationale. approaches, and recent clinical developmentJohannes Volk, Saadettin Sel, Arnold Ganser, et al.
British Journal of Haematology|July 26, 2002
Persistent aplasia after chemotherapy for acute myeloid leukaemia treated with stem cell transplantation from a matched unrelated donor after dose-reduced conditioningLothar Hambach, Gerhard Heil, Bernd Hertenstein, et al.
Medizinische Klinik (Munich, Germany : 1983)|November 16, 2002
[Myelodysplastic syndromes. Diagnosis and therapeutic strategies]Carlo Aul, Aristoteles Giagounidis, Ulrich Germing, et al.
Pageof 58